AzTrials
AzTrials

Airway ManagementSAVERNCT07249983

Evaluation of SaCoVLM™ Video Laryngeal Mask for Airway Management in Military Medics

A study testing SaCoVLM™ Video Laryngeal Mask in people with Airway Management and Tracheal Intubation, run by Charles University, Czech Republic at 1 site in Czechia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

A prospective, two-phase interventional study evaluating the performance, safety, and usability of the SaCoVLM™ video laryngeal mask airway for airway management by military medics with limited intubation experience. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Airway Management, Tracheal Intubation, Anesthesia
What is being tested?
SaCoVLM™ Video Laryngeal Mask
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteCzechia
Study dates
1 Mar 2026to Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Elective surgery
  • ASA I-II
  • need for airway management

Who cannot join

  • Pregnancy
  • known airway abnormalities
  • allergy to anesthetics

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jan Palenik, M.D. contact

+420973203254

jan.palenik@uvn.cz

Ladislav Šindelář, M.D. contact

+420973202999

ladislav.sindelar@uvn.cz

Czechia1 site, 1 recruiting
  • Military University Hospital Prague

    Prague, Prague, 16209

    Michal Sotak, M.D., Ph.D., +420774830710, michal.sotak@uvn.cz

    Recruiting

Other trials in Czechia

About this study

Official title: Evaluation of SaCoVLM™ Video Laryngeal Mask Airway for Airway Management by Inexperienced Military Medics: A Two-Phase Feasibility Study

A prospective, two-phase interventional study evaluating the performance, safety, and usability of the SaCoVLM™ video laryngeal mask airway for airway management by military medics with limited intubation experience. The study includes simulation-based training and clinical application in sedated patients undergoing elective surgery.

Read the detailed description

This prospective, two-phase study evaluates the use of the SaCoVLM™ video laryngeal mask airway by military medics with limited airway experience. Phase 1 involves simulated intubation on manikins to assess device placement, visualization quality, and intubation success. Phase 2 evaluates clinical performance in adult patients undergoing elective surgery under general anesthesia. Key outcomes include first-attempt success rates, insertion and intubation times, glottic visualization scores, and complication rates. The study aims to determine whether SaCoVLM™ can enable safe and effective airway management in resource-limited and prehospital military settings.

Being tested
SaCoVLM™ Video Laryngeal Mask
Keywords
SaCoVLM™, Video Laryngeal Mask, Military Medic Training, Emergency Airway

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SaCoVLM™ Video Laryngeal MaskDevice

    Simulation-based and clinical use of SaCoVLM™ for airway management and intubation.

Study groups in NCT07249983
Study groupRoleWhat they receive
Simulation and Clinical PhaseExperimentalSimulation-based and clinical use of SaCoVLM™ for airway management and intubation.
Receives: Device: SaCoVLM™ Video Laryngeal Mask

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. First-Attempt Success Rate of SaCoVLM™ Insertion

    Proportion of cases in which the SaCoVLM™ is successfully inserted on the first attempt during both simulated and clinical phases.

    Measured: Within 10 minutes of airway intervention.

  2. First-Attempt Success Rate of Orotracheal Intubation via SaCoVLM™

    Proportion of successful orotracheal intubations on the first attempt using the SaCoVLM™ device as a conduit.

    Measured: Within 10 minutes following SaCoVLM™ placement.

Secondary outcomes (5)
  1. Time to SaCoVLM™ Insertion

    Time in seconds from picking up the device to successful confirmation of placement.

    Measured: During initial airway management (simulation or clinical setting).

  2. Time to Successful Intubation

    Time in seconds from introduction of the endotracheal tube into the SaCoVLM™ to confirmed tracheal placement.

    Measured: During initial airway management (simulation or clinical setting).

  3. Glottic Visualization Score

    Laryngeal view quality assessed using Keller-Brimacombe scale. The Keller-Brimacombe score ranges from Grade 1 (vocal cords not visible) to Grade 4 (only vocal cords visible with a full, unobstructed view), with higher grades indicating better glottic visualization and alignment for intubation.

    Measured: Immediately after SaCoVLM™ placement.

  4. Subjective Difficulty Score

    Operator-rated difficulty of device use on a 10-point visual analog scale (VAS).

    Measured: Immediately after each procedure.

  5. Incidence of Airway Complications

    Number of adverse airway events including hypoxemia (SpO₂ < 90%), laryngospasm, or aspiration.

    Measured: From initiation of airway management to induction of general anesthesia (clinical phase only).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2025
  2. Study start1 Mar 2026
  3. Primary completionDec 2026 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07249983
Sponsor's protocol ID
SAVER-2025
Acronym
SAVER
Status last verified
Apr 2026
First submitted
18 Nov 2025
Last updated
21 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Mishra N, Bharadwaj A. Comparison of Fiberoptic-Guided Tracheal Intubation Through Intubating Laryngeal Mask Airway (ILMA) FastrachTM and Ambu(R) Aura-i: A Randomized Clinical Study. Cureus. 2020 Sep 1;12(9):e10178. doi: 10.7759/cureus.10178.

    PubMed 33029458

Questions about this trial

What is this clinical trial studying?

A study testing SaCoVLM™ Video Laryngeal Mask in people with Airway Management and Tracheal Intubation, run by Charles University, Czech Republic at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jan Palenik, M.D. (+420973203254, jan.palenik@uvn.cz), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

First-Attempt Success Rate of SaCoVLM™ Insertion (time frame: Within 10 minutes of airway intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07249983, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in